Lanean...
The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells
With the emergence of Src inhibitors in clinical trials, improved knowledge of the molecular responses of cancer cells to these agents is warranted. This will facilitate the development of tests to identify patients who may benefit from these agents, allow drug activity to be monitored and rationali...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2009
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2716757/ https://ncbi.nlm.nih.gov/pubmed/19240653 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31819c78fb |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|